These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1549775)
1. The ability of certain SIV vaccines to provoke reactions against normal cells. Langlois AJ; Weinhold KJ; Matthews TJ; Greenberg ML; Bolognesi DP Science; 1992 Jan; 255(5042):292-3. PubMed ID: 1549775 [No Abstract] [Full Text] [Related]
2. Vaccination against SIV infection and disease. Gardner MB AIDS Res Hum Retroviruses; 1990 Jul; 6(7):835-46. PubMed ID: 2167709 [No Abstract] [Full Text] [Related]
3. Protection against human immunodeficiency virus type 2 and simian immunodeficiency virus in macaques vaccinated against human immunodeficiency virus type 2. Biberfeld G; Thorstensson R; Putkonen P AIDS Res Hum Retroviruses; 1996 Mar; 12(5):443-6. PubMed ID: 8882330 [No Abstract] [Full Text] [Related]
4. Characterization of group specific antibodies in primates: studies with SIV envelope in macaques. Haigwood NL; Misher L; Chin SM; Blair M; Planelles V; Scandella CJ; Steimer KS; Gardner MB; Yilma T; Hirsch VM J Med Primatol; 1992; 21(2-3):82-90. PubMed ID: 1433271 [TBL] [Abstract][Full Text] [Related]
5. Detection of anti-human cell antibodies in sera from macaques immunized with whole inactivated virus. Langlois AJ; Weinhold KJ; Matthews TJ; Greenberg ML; Bolognesi DP AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1641-52. PubMed ID: 1457210 [TBL] [Abstract][Full Text] [Related]
6. A formalin-fixed whole SIV vaccine induces protective responses that are cross-protective and durable. Murphey-Corb M; Ohkawa S; Davison-Fairburn B; Martin LN; Baskin GB; Langlois AJ; McIntee M; Narayan O; Gardner MB AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1475-8. PubMed ID: 1466986 [No Abstract] [Full Text] [Related]
7. Inactivated whole SIV vaccine in macaques: evaluation of protective efficacy against challenge with cell-free virus or infected cells. Johnson PR; Montefiori DC; Goldstein S; Hamm TE; Zhou J; Kitov S; Haigwood NL; Misher L; London WT; Gerin JL AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1501-5. PubMed ID: 1466990 [No Abstract] [Full Text] [Related]
8. Summary of the SIV Working Group. Schultz AM AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1439-40. PubMed ID: 1466977 [No Abstract] [Full Text] [Related]
9. Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virus. Cranage MP; Baskerville A; Ashworth LA; Dennis M; Cook N; Sharpe S; Farrar G; Rose J; Kitchin PA; Greenaway PJ Lancet; 1992 Feb; 339(8788):273-4. PubMed ID: 1346285 [TBL] [Abstract][Full Text] [Related]
10. Protection of macaques against simian immunodeficiency virus infection with inactivated vaccines: comparison of adjuvants, doses and challenge viruses. The European Concerted Action on 'Macaque Models for AIDS Research'. Vaccine; 1995 Feb; 13(3):295-300. PubMed ID: 7631516 [TBL] [Abstract][Full Text] [Related]
11. SIV and FIV vaccine studies at UC Davis: 1991 update. Gardner M; Yamamoto J; Marthas M; Miller C; Jennings M; Rosenthal A; Luciw P; Planelles V; Yilma T; Giavedoni L AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1495-8. PubMed ID: 1334682 [No Abstract] [Full Text] [Related]
12. Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins. Lifson JD; Rossio JL; Piatak M; Bess J; Chertova E; Schneider DK; Coalter VJ; Poore B; Kiser RF; Imming RJ; Scarzello AJ; Henderson LE; Alvord WG; Hirsch VM; Benveniste RE; Arthur LO AIDS Res Hum Retroviruses; 2004 Jul; 20(7):772-87. PubMed ID: 15307924 [TBL] [Abstract][Full Text] [Related]
13. Modern vaccines. Human immunodeficiency virus and AIDS: challenges and progress. Schild GC; Minor PD Lancet; 1990 May; 335(8697):1081-4. PubMed ID: 1970381 [No Abstract] [Full Text] [Related]
14. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV. Marthas ML; Miller CJ; Sutjipto S; Higgins J; Torten J; Lohman BL; Unger RE; Ramos RA; Kiyono H; McGhee JR J Med Primatol; 1992; 21(2-3):99-107. PubMed ID: 1433273 [TBL] [Abstract][Full Text] [Related]
15. Lymphoproliferative responses in macaques immunized with inactivated SIV vaccine. Teng XC; Ashworth LA; Sharpe SA; Dennis MJ; Cranage MP AIDS Res Hum Retroviruses; 1993 Aug; 9(8):799-801. PubMed ID: 8217348 [No Abstract] [Full Text] [Related]
16. Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines. Heeney JL; de Vries P; Dubbes R; Koornstra W; Niphuis H; ten Haaft P; Boes J; Dings ME; Morein B; Osterhaus AD J Med Primatol; 1992; 21(2-3):126-30. PubMed ID: 1433263 [TBL] [Abstract][Full Text] [Related]
17. Simian immunodeficiency virus live and inactivated experimental vaccines. Norley S; Beer B; Binninger-Schinzel D; Vogel T; Siegel F; Cosma C; König H; Megede JZ; Kurth R AIDS Res Hum Retroviruses; 1996 Mar; 12(5):447-9. PubMed ID: 8882331 [No Abstract] [Full Text] [Related]
18. Virus-specific helper T cell response of macaques immunized with inactivated whole SIV is not correlated with reactivity against cellular components of vaccine preparation. Dittmer U; Lüke W; Stahl-Hennig C; Hunsmann G; Voss G AIDS Res Hum Retroviruses; 1994 Apr; 10(4):329-30. PubMed ID: 8068411 [No Abstract] [Full Text] [Related]
19. Prototype AIDS vaccine works in monkeys. Am Pharm; 1990 Feb; NS30(2):5. PubMed ID: 2106250 [No Abstract] [Full Text] [Related]
20. Whole inactivated SIV vaccine grown on human cells fails to protect against homologous SIV grown on simian cells. Putkonen P; Nilsson C; Hild K; Benthin R; Cranage M; Aubertin AM; Biberfeld G J Med Primatol; 1993; 22(2-3):100-3. PubMed ID: 8411101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]